Delaying Aging More Effective, Cost-Efficient Than Targeting Diseases, Study Shows

Slowing the aging process may be the most effective and cost-efficient strategy for preventing and slowing disease, extending healthy life years and improving public health, according to a study published in Health Affairs.

Advertisement

Researchers ran a simulation called the Future Elderly Model, which compared longevity, disability and entitlement program costs in both “disease specific” and “delayed aging” scenarios.

In the model scenario in which healthcare focused on delaying aging, individuals lived an average of 2.2 years longer, most of that time in good health, than individuals in the scenario where healthcare focused on targeting specific diseases.

In addition, the delaying aging model saved $7.1 trillion over 50 years. Though entitlement outlays increased, these costs were offset by increasing the Medicare eligibility age and the Social Security Retirement age.

The study concluded the healthcare system and the American population could benefit from a paradigm shift in care and research goals.

More Articles on Quality:

3 Strategies for Quality Improvement from Joint Commission CEO Dr. Mark Chassin

High Readmissions From Low Patient Activation, Study Finds

Case Study: Physician Incentives Key to Quality Improvements at Mass General

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

  • How many of you have felt like a flea in a jar? If you put fleas in a jar, they…

Advertisement

Comments are closed.